logo
Select company
Select metric
$ -10.33MConsolidated Income
VS
Market
35
Sector
66
Industry
80
History
27
$ 4.22Close
$ 4.15 - $ 16.1 52-Week Range
Ticker Information

Ticker

DRMA

Company Name

DERMATA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DERMATA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DRMA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -10.33M
3/31/2025$ -11.46M
12/31/2024$ -12.29M
9/30/2024$ -11.27M
6/30/2024$ -9.82M
3/31/2024$ -8.69M
12/31/2023$ -7.79M
9/30/2023$ -7.33M
6/30/2023$ -8.04M
3/31/2023$ -9.06M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DERMATA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -3.24M.
  • Over the past 5 years, DERMATA THERAPEUTICS INC's average Cons. Inc. has been $ -9.09M.
  • The median Cons. Inc. for DERMATA THERAPEUTICS INC during this period was $ -9.34M
  • DERMATA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -3.24M.
  • The lowest Cons. Inc. recorded by DERMATA THERAPEUTICS INC in the same timeframe $ -12.29M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

DRMA - Consolidated Income, Last 5 years

$ -12.29M

Minimum

Dec 31, 2024

$ -3.24M

Maximum

Dec 31, 2020

$ -9.09M

Average

$ -9.34M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M